ArticleOncotarget2018

CRISPR knock out of programmed cell death protein 1 enhances anti-tumor activity of cytotoxic T lymphocytes.

Zhilong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.